Qube Research & Technologies (QRT)
CRVO icon

Qube Research & Technologies (QRT)’s CervoMed CRVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,021
Closed -$65.6K – 3542
2024
Q4 		$65.6K Buy
+28,021
New +$272K ﹤0.01% 3058

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRVO Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of CervoMed (CRVO) in Q1 2025, closing a stake of 28,021 shares — an estimated $65.6K sold.

Qube Research & Technologies (QRT) first reported a position in CRVO in Q4 2024 and held it in 1 quarter. The position peaked at $65.6K in Q4 2024. 48 funds tracked by Wall St. Rank hold CRVO as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining CervoMed position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 28,021 CervoMed shares in Q1 2025, an estimated $65.6K.
  • Qube Research & Technologies (QRT) first reported a position in CervoMed in Q4 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s CervoMed position peaked at $65.6K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held CervoMed as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.